New techniques are on the horizon for the detection of small leukemic clones in both, acute leukemias and myeloproliferative disorders. A promising approach is based on digital polymerase chain reaction (PCR). Digital PCR (dPCR) is a breakthrough technology designed to provide absolute nucleic acid quantification. It is particularly useful to detect a low amount of target and therefore it represents an alternative method for detecting measurable residual disease (MRD). The main advantages are the high precision, the very reliable quantification, the absolute quantification without the need for a standard curve, and the excellent reproducibility. Nowadays the main disadvantages of this strategy are the costs that are still higher than standard qPCR, the lack of standardized methods, and the limited number of laboratories that are equipped with instruments for dPCR. Several studies describing the possibility and advantages of using digital PCR for the detection of specific leukemic transcripts or mutations have already been published. In this review we summarize the available data on the use of dPCR in acute myeloid leukemia and myeloproliferative disorders.

Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?

Cilloni, Daniela
Co-first
;
Petiti, Jessica;Rosso, Valentina;Andreani, Giacomo;Dragani, Matteo;Fava, Carmen;Saglio, Giuseppe
Last
2019-01-01

Abstract

New techniques are on the horizon for the detection of small leukemic clones in both, acute leukemias and myeloproliferative disorders. A promising approach is based on digital polymerase chain reaction (PCR). Digital PCR (dPCR) is a breakthrough technology designed to provide absolute nucleic acid quantification. It is particularly useful to detect a low amount of target and therefore it represents an alternative method for detecting measurable residual disease (MRD). The main advantages are the high precision, the very reliable quantification, the absolute quantification without the need for a standard curve, and the excellent reproducibility. Nowadays the main disadvantages of this strategy are the costs that are still higher than standard qPCR, the lack of standardized methods, and the limited number of laboratories that are equipped with instruments for dPCR. Several studies describing the possibility and advantages of using digital PCR for the detection of specific leukemic transcripts or mutations have already been published. In this review we summarize the available data on the use of dPCR in acute myeloid leukemia and myeloproliferative disorders.
20
9
2249
--
acute myeloid leukemia; chronic myeloproliferative disorders; digital PCR; minimal residual disease
Cilloni, Daniela; Petiti, Jessica; Rosso, Valentina; Andreani, Giacomo; Dragani, Matteo; Fava, Carmen; Saglio, Giuseppe
File in questo prodotto:
File Dimensione Formato  
Cilloni_ijms-20-02249.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 581.46 kB
Formato Adobe PDF
581.46 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1701713
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 30
social impact